# Denali Therapeutics Inc.: Form 8-K, filed Jun 3, 2025

- Company: [Denali Therapeutics Inc.](/companies/dnli.md) (CIK 1714899)
- Form: 8-K
- Filed: 2025-06-03
- Accepted by EDGAR: Jun 3, 2025, 16:05 ET
- Period: 2025-06-03
- Accession: 0001714899-25-000128
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1714899/000171489925000128/dnli-20250603.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1714899/000171489925000128/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1714899/000171489925000128/dnli-20250603.htm

Filed Jun 3, 2025.
Source: SEC EDGAR, the filing index for accession 0001714899-25-000128. Last ingested by Listed: Nov 3, 2026, 19:01 ET. No prices; not investment advice.